Job Opening in Enviroway Bio-Science Pvt.Ltd

Job Opportunity in Bayer Crop Science

Job Opening in Logotech India Pvt.Ltd.

Pharma cos agree to code on freebies

Optra systems joins Microsoft in its BIO-IT alliances initiative for life science image informatics

Optra system a leading life science and healthcare IT consulting company announced its joining the Microsoft BioIT alliances.
“We are delighted to welcome Optra system in to the BioIT alliances,” said Dr. Rudy Potenzone, Director of the alliance and Worldwide Pharmaceutical industry technology Strategies. “Optra system expertise in Life science and Healthcare Image Informatics space and a range of solutions for preclinical and clinical imaging adds a new perspective to the BioIT Alliance.
Abhi Gopalap, President and CEO of Optra System said “We are pleased to be a member of the Microsoft BioIT Alliance, we look forward to work closely with Microsoft and the other Alliance members. OPTRA with its array of solutions and offerings would enable the alliance members make more effective use of technology for research and development and advancing new products.” Optra systems has been a key partner for many life science and healthcare companies for developing complete workflow management including Image acquisition, storage, processing, analyzing and reporting. OPTRA has a vast experience and is supporting renowned academic institutions to speed up their research in Bioinformatics, Systems Biology, and Translational Medicine. Many pharmaceutical and Biotech companies rely on Optra for their needs like system integration, enterprise and business intelligence, data integration management, etc. Optra system is also partnering with microscopy and instrumentation companies to develop new products and solutions.
The Alliance brings together pharmaceutical, biotechnology, hardware, and software industries to explore new ways to share complex biomedical data and collaborate among multi-disciplinary teams to expedite discovery in the life sciences. It also enables the members to identify new technologies to over come the challenges faced by life science companies like data integration, collaboration, and knowledge management that cannot be solved by any organization alone.
Source: Life sciences Industry News

Flourishing Third Party Regulatory Business

Business is booming for Third party regulatory compliance and quality assurance professionals/vendors.Moreover they are in high demand for regulatory related activities performed in Medical device industry,Pharmaceutical industry,Biotech industry,CROs.As markets are facing cut throat competition,less time to market is most important..Investors are eager to see streamlined, mistake-free production with a minimum amount of rework, which means quality is a high-level concern.Globalization leads to increased outsourcing of manufacturing of products and components overseas where different sets of rules and regulation could impact outcomes.Non compliance of medical devices and various pharmaceutical products leads to charges of fraud.Subsequently have made many medical devices and pharmaceutical companies aware of the importance and need for compliance majorly in their supply chain and offshore operations Medical device industries and pharmaceutical companies majorly outsourced their product compliance tasks to third party regulatory compliance professionals,the basic idea behind the compliance outsourcing is to make their products reach Indian and international markets without risk of non-compliance.FDA inspections have focused on supplier management; a majority of its warning letters cite companies for failing to adequately control products purchased from their suppliers Employing specialized third parties for regulatory compliance by medical device and pharmaceutical companies with specific domain regulatory expertise and well versed regulatory professionals again who excelled the particular regulatory domain can help companies successfully navigate this complexity Moreover the Indian government is introducing stringent rules and regulations,to heightened awareness within the device and product community for the importance of regulatory compliance and thus to safeguard the individual and national health Companies are hiring third party as they have potential to provide significantally tremendous value rather than performing in house regulatory activities Numerous companies pay in the range of $250,000-$300,000 to regulatory and quality control personnel for inhouse regulatory works.Instead same companies believes in paying third party consultant 20% of that amount to do the work

Dear admin;

since one month i am mailing for original certificates.  i hav called number of times. the response last time was u hav posted certificates through registered post on 23 rd december to me. till now i didnt receive anything. this is very bad on your part. do the needful ASAP. I hav cleared all papers in pharma regulatory affairs in april 2008.

with regards

RAMARAJU SRINIVASARAO

S07PRAF10094

INDUSTRIAL PROGRAMME IN PHARMA REGULATORY AFFAIRS

Biotech Proposals

Visit : http://www.dbtindia.gov.in/ or http://www.dbtindia.nic.in/

Source :The Economic Times

DBT invites proposals from Biotech companies/Entrepreneurs For Innovative,early stage of available innovative research leads in biotechnology.

Career in Pharmacy

Source: HT Horizons

Jawaharlal Nehru Centre for Advanced Scientific Research

Source: The Times of India

analytica Anacon India 2009

analytica Anacon India is an Indian trade fair with conference with international character designed to take exhibitors to new-developping marketplaces of significant interest. The concept has been transferred from the world- leading trade fair analytica in Munich which guarantees a high participation of international exhibitors and market leaders.

This year it will be held for the second time in Hyderabad, the home of India's biochemical and pharmaceutical industry.

Date: Sept 29 - Oct 01
venue: HITEX EXHIBITION CENTRE
HYDERABAD,INDIA
Opening Hours: 10.00 - 18.00
Entrance: The entrance is free upon registration, for trade visitors only.

Exhibition sectors:
- Analysis
- Measuring and teting / Quality Control
- Laboratory Technology
- Life Sciences and Biotechnology
- Medicine and Diagnostics

Visitor target Groups:

analytica Anacon India addresses Indian users and decision makers of the following sectors
- Chemicals and petrochemicals industries
- Pharmaceuticals industry
- Medical and diagnostics industries
- Environmental protection
- Electronics and electrical engineering
- Industrial research and development
- Public-sector research and development
- Public authorities / public facilities / universities / research institutions


Contact:
For exhibitors from India:

Sonia Prashar
Indo-German Chamber of Commerce
German House 2, Nyaya Marg
Chanakyapuri, New Delhi
phone: (+91) 11 26878721 or 26111730
E-mail: soniaprashar(a)indo-german.com

Assignments Submission

Dear Sir/Madam,

I am enrolled in Spring 2008 Batch for Pharma Regulatory Affairs.
Can I know the extended date for assignments & Research study to be eligible for the April 2009 Examinations

Regards,
Deepak.P

A Comprehensive Biotech Growth

Souce:The Hindustan Times

One Day Workshop on Clinical Trials - 7th mar'09 by BII

Workshop Clinical Trials

View SlideShare document or Upload your own.

One day Workshop on Bioinformatics - 7th Feb'09 by BII

Workshop Bioinformatics

View SlideShare document or Upload your own.